2013
DOI: 10.1016/j.jamda.2013.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Evidence-Informed Guidelines for Treating Frail Older Adults With Type 2 Diabetes: From the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) Program

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
60
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 77 publications
(60 citation statements)
references
References 65 publications
0
60
0
Order By: Relevance
“…Both hyper-and hypoglycemia can lead to cognitive decline [59][60][61][62][63]. In addition, hypertriglyceridemia is associated with poor cognitive function [64,65], possibly by impairing the ability of leptin to cross the blood brain barrier [66,67].…”
Section: Associations With Heart Failure and Cognitive Declinementioning
confidence: 99%
“…Both hyper-and hypoglycemia can lead to cognitive decline [59][60][61][62][63]. In addition, hypertriglyceridemia is associated with poor cognitive function [64,65], possibly by impairing the ability of leptin to cross the blood brain barrier [66,67].…”
Section: Associations With Heart Failure and Cognitive Declinementioning
confidence: 99%
“…Careful monitoring of oral intake is warranted. The decision process may need to involve the patient, family, and caregivers, leading to a care plan that is both convenient and effective for the goals of care (26). The pharmacological therapy may include oral agents as first line, followed by a simplified insulin regimen.…”
Section: End-of-life Carementioning
confidence: 99%
“…Careful monitoring of oral intake is warranted. The decision process may need to involve the patient, family, and caregivers, leading to a care plan that is both convenient and effective for the goals of care (46). The pharmacologic therapy may include oral agents as first line, followed by a simplified insulin regimen.…”
Section: End-of-life Carementioning
confidence: 99%